Cancer is currently considered one of the health crises that have threatened people in Thailand and around the world for many years. But the outbreak of the COVID-19 virus Since the end of 2019, the workload of medical personnel has increased. And it is also a big obstacle to patients' access to treatment. Especially cancer patients who are considered a group at high risk of infection. Therefore, the medical community must adapt in time. Whether it is the development of telemedicine technology (Telemedicine) or the development of various applications, including diagnostic and treatment innovations that help shorten hospital time for patients. This reduces the risk of exposure to carriers or germs. and also reduces congestion in hospitals
Traditionally, intravenous injections have been administered in hospitals for several hours per round. To meet the increasing demand in terms of promoting a better quality of life for breast cancer patients and their caregivers. Including in terms of upgrading the health care system. An innovation has been developed for cancer patients as a drug injected under the skin. This is considered a new way of medicine that helps facilitate cancer patients living in Thailand. Black pepper is the most common treatment for chemotherapy. Each time takes quite a long time. As a result, patients need to spend less time in the hospital and reduce the risk of contracting the COVID-19 virus. Including helping to relieve anxiety for patients and caregivers who have to come to the hospital.ย
Dr. Piyawan Thianchaianan Medical Oncologist Rajavithi Hospital Said: “Due to the spread of the COVID-19 virus As a result, patients requiring hospital services and medical personnel face barriers to treatment. Cancer patients are a group that is more affected than general patients. This is because they are a group of patients who are at high risk of developing complications from infections more easily and more severely than the general population. Currently, medical innovations for cancer treatment are very advanced and modern, such as targeted drug therapy that specifically acts on HER-2 positive breast cancer cells by injecting the drug under the skin. This innovation has been developed to have better treatment efficiency. It combines two targeted drugs in a single needle and is administered by injection under the skin. Two HER-2-targeted drugs delivered in the same subcutaneous needle have been clinically proven to be as effective as intravenous drugs2. Two types of HER-2 targeting drugs reduce the risk of the disease coming back. and significantly increase the survival rate of patients with HER-2 positive breast cancer at all stages3-5 It also allows patients to save up to 90% of their time receiving medication compared to intravenous injections, from three to four hours per session. There are only a few minutes left. As a result, the patient's quality of life improves. It also helps relieve the burden on medical personnel. and reduce congestion in hospitals1
This continued advancement in cancer care is the result of the commitment of all stakeholders working together to promote innovation in personalized healthcare. Public health service providers can respond and manage the cancer threat in the COVID-19 pandemic. effectively “Roche Thailand aims to continually increase survival rates and improve the quality of life of patients. Through research and development of innovative diagnostics and treatments based on state-of-the-art science, we also build partnerships with all stakeholders. Whether it is medical personnel Government agencies and the private sector to drive access to treatment for patients in Thailand to be more comprehensive and equitable. Especially breast cancer, which is a disease that has a chance of being cured and has a high survival rate. If breast cancer patients have access to quality treatment early.”
Farid Bidgoli, General Manager, Roche Thailand, Myanmar, Cambodia and Laos In closing, he said, "Innovative treatment for breast cancer patients uses a combination of two targeted drugs in the same needle and injects the drug under the skin. It is considered an important step in medical science to improve treatment outcomes for patients. Amidst the current COVID-19 outbreak situation, time has become a key variable in receiving hospital services. Therefore, prompt and effective treatment helps cancer patients and their caregivers reduce the risk of exposure to carriers or pathogens. At the same time, the more flexible work of medical personnel also helps reduce congestion in hospitals. This allows medical personnel to provide services to more patients as well."
Reference:
1. O’Shaughnessy J, Sousa S, Cruz J, et al. Annal Oncol.2020; 31: S306-S307
2. Tan AR, Im S-A, Mattar A, et al. Lancet Oncol. 2020; (published online Dec21.)
3. Swain SM, Baselga J, Kim SB, et al. N Engl J Med. 2015; 372:724-734
4. Gianni L, Pienkowski T, et al. Lancet Oncol 2016; 17: 791–800
5. Von Minckwitz G, Procter M, et al. N Engl J Med. 2017;377:122-31.
0 Comments